Bedoradrine
- Generic Name
- Bedoradrine
- Drug Type
- Small Molecule
- Chemical Formula
- C24H32N2O5
- CAS Number
- 194785-19-8
- Unique Ingredient Identifier
- 4EAR229231
- Indication
Investigated for use/treatment in asthma and labor and delivery.
Safety Study to Evaluate MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients
Phase 1
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-03-12
- Last Posted Date
- 2012-05-21
- Lead Sponsor
- MediciNova
- Target Recruit Count
- 19
- Registration Number
- NCT01551316
- Locations
- 🇺🇸
Central Texas Health Research, New Braunfels, Texas, United States
🇺🇸Sylvana Research Associates, San Antonio, Texas, United States
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
- First Posted Date
- 2009-02-06
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- MediciNova
- Target Recruit Count
- 176
- Registration Number
- NCT00838591
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸Albert Einstein Healthcare Network, Philadelphia, Pennsylvania, United States
🇺🇸Baystate Medical Center, Springfield, Massachusetts, United States
Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma
- First Posted Date
- 2008-05-16
- Last Posted Date
- 2011-12-19
- Lead Sponsor
- MediciNova
- Target Recruit Count
- 17
- Registration Number
- NCT00679263
- Locations
- 🇺🇸
PRA International, Lenexa, Kansas, United States
🇺🇸Northeast Medical Research Associates, North Dartmouth, Massachusetts, United States
🇺🇸Clinical Research of the Ozarks, Rolla, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath